Gastrointestinal (GI): NSAIDs that block COX-one action have correlations with GI problems a result of the inhibition in the synthesis of gastroprotective agents for example PGE2 and other prostaglandins. This inhibition causes lessened mucin manufacturing by gastric epithelial cells, significantly less bicarbonate secretion, and less epithelial cell turnover, among other https://dalel414rvd5.blogginaway.com/profile